GlassScriptPhysician profile
Noggy David Jaen
NPI 1457877151
$770.13
in general payments reported to CMS, 2019-2025
19 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.69 · 2024: $334 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $108.19 | 2024-2025 | Prevymis, Zerbaxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.69 | 2021 | |
| Abbvie INC. | $71.09 | 2024 | |
| Edwards Lifesciences Corporation | $61.82 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.48 | 2025 | Livtencity |
| Cormedix INC. | $47.83 | 2025 | Defencath |
| Avita Medical Americas, LLC | $46.54 | 2024 | |
| Shionogi INC | $42.52 | 2024 | Fetroja |
| Bayer Healthcare Pharmaceuticals INC. | $32.35 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.44 | 2025 | Jardiance |
| Travere Therapeutics, INC. | $27.65 | 2025 | |
| Teleflex LLC | $26.99 | 2024 | Arrow |
| Amgen INC. | $26.25 | 2025 | Krystexxa |
| My01 INC. | $23.13 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Mallinckrodt Hospital Products INC. | $21.47 | 2025 | Acthar |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.77 | 2025 | Farxiga |
| Smith+Nephew, INC. | $19.55 | 2024 | Versajet |
| Melinta Therapeutics, LLC | $18.28 | 2024 | Rezzayo |
| Alexion Pharmaceuticals, INC. | $14.09 | 2025 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noggy Jaen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.